RX2World.com: Your Pharmacy Guide - Page 3

Epilepsy affects 50 million people worldwide. Understanding seizure types, triggers, and how antiepileptic drugs work can improve diagnosis and treatment. Learn how the 2025 classification system helps doctors choose the right care.

Counterfeit drugs in developing nations kill tens of thousands annually, with fake medicines containing no active ingredients or toxic chemicals. Learn how they spread, why they're so dangerous, and what's being done to stop them.

Pregnancy can disrupt sleep due to apnea, reflux, and positioning issues. Learn how CPAP, side sleeping, and proper elevation can reduce risks and improve rest during pregnancy.

Doctors need ongoing education on generic medications to prescribe safely, improve adherence, and reduce costs. With 90% of prescriptions now generic, CME must evolve beyond checklists to real-world, patient-centered learning.

Warfarin users must avoid common OTC cold medications like ibuprofen and aspirin to prevent dangerous bleeding. Learn which ingredients are safe, how to read labels, and what to do when you're sick - backed by clinical data and real patient stories.

Digital eye strain affects millions daily. Learn simple, science-backed ways to prevent Computer Vision Syndrome-like the 20-20-20 rule, proper screen setup, and blinking habits-without expensive gear.

FDA inspections of generic drug manufacturing facilities are routine but rigorous. Learn what inspectors look for, how to prepare, and what happens if issues are found-all based on current 2026 regulations and real-world practices.

Retinal vein occlusion can cause sudden vision loss. Learn the key risk factors like high blood pressure and diabetes, and how anti-VEGF injections help restore vision. Understand treatment options, costs, and what to expect.

Therapeutic drug monitoring helps protect patients on generic HIV drugs by measuring blood levels to prevent toxicity and treatment failure-especially for protease inhibitors and NNRTIs. Not for all drugs, but critical in high-risk cases.

Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.